← Back to Search

Alcohol Skin Solutions for Broken Bones (PREPARE Trial)

Phase 4
Waitlist Available
Led By Gerard Slobogean, MD
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fracture management requires a surgical incision (i.e., for fracture reduction or implant insertion)
Open fracture of the appendicular skeleton
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days of the patient's last planned fracture management surgery
Awards & highlights

PREPARE Trial Summary

This trial is testing different solutions to see which one is the best at preventing infection in people with broken bones.

Who is the study for?
Adults over 18 with open fractures needing surgery within 72 hours of injury can join. They must be treated by a participating surgeon, consent to the study, and not be in conflicting trials or have communication barriers.Check my eligibility
What is being tested?
The trial is testing two skin cleaning solutions, DuraPrep and ChloraPrep, used before surgery on broken bones to prevent infections. It aims to find out which one is better at reducing bacteria and infection risks.See study design
What are the potential side effects?
Potential side effects from DuraPrep and ChloraPrep may include skin irritation or allergic reactions at the application site. However, these are generally mild as they're topical antiseptics.

PREPARE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need surgery for a fracture.
Select...
I have a broken bone that is exposed through my skin.
Select...
I have had or will have surgery to fix a bone fracture using implants.
Select...
My fracture surgery will be done by a surgeon in the trial.
Select...
I have a closed fracture in my leg or pelvis.

PREPARE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days of the patient's last planned fracture management surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days of the patient's last planned fracture management surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Surgical Site Infection: Deep Incision or Organ/Space
Surgical Site Infection: Superficial Incisional
Secondary outcome measures
Unplanned Fracture-Related Reoperation

PREPARE Trial Design

2Treatment groups
Experimental Treatment
Group I: First pre-op antiseptic skin solutionExperimental Treatment2 Interventions
The PREPARE trial will compare the most common alcohol-based pre-operative antiseptic skin solutions used during extremity fracture surgery. Participant recruitment will begin with the clinical sites using their assigned pre-operative antiseptic skin solution for all eligible fracture surgeries for a two-month period.
Group II: Crossover - Second pre-op antiseptic skin solutionExperimental Treatment2 Interventions
Once the first intervention phase is completed, each site will crossover to the opposite study solution. Each site will need to develop local procedures to ensure a successful crossover. They will use the second solution for all eligible fracture surgeries for a two-month period, and will then crossover back to the solution in the first intervention phase.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DuraPrep
2010
Completed Phase 4
~230
Isopropyl alcohol
FDA approved

Find a Location

Who is running the clinical trial?

McMaster UniversityOTHER
880 Previous Clinical Trials
2,589,828 Total Patients Enrolled
University of Maryland, BaltimoreLead Sponsor
687 Previous Clinical Trials
366,646 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,988,776 Total Patients Enrolled

Media Library

DuraPrep Clinical Trial Eligibility Overview. Trial Name: NCT03523962 — Phase 4
Leg Fracture Research Study Groups: Crossover - Second pre-op antiseptic skin solution, First pre-op antiseptic skin solution
Leg Fracture Clinical Trial 2023: DuraPrep Highlights & Side Effects. Trial Name: NCT03523962 — Phase 4
DuraPrep 2023 Treatment Timeline for Medical Study. Trial Name: NCT03523962 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are enrolled in this experiment?

"Enrollment for this medical trial has been halted. It was initially posted on August 21st of 2018 and edited most recently on November 8th 2022. If you are looking to participate in a clinical study, there are currently 431 trials related to unplanned fracture-related reoperation that need participants as well as 47 studies focused on DuraPrep."

Answered by AI

How prevalent is this empirical research in our state?

"Patients are currently being accepted into this trial at the University of Cincinnati Medical Centre, Bryan Health in Lincoln, Nebraska and Royal Columbia Hospital in New Westminster, British Columbia. Additionally, there are 24 other locations participating in the study."

Answered by AI

To what ailments is DuraPrep regularly administered?

"DuraPrep is commonly used to create antisepsis, but it has additional applications such as disinfection and treating injuries in the throat or pressure ulcers."

Answered by AI

Is the team behind this study still seeking participants?

"Per the data on clinicaltrials.gov, this particular study is not actively seeking applicants at present. The trial was first posted in August 2018 and most recently updated in November 2022. Nonetheless, there are currently 478 other medical trials recruiting volunteers around the world right now."

Answered by AI

Is DuraPrep an accepted medical device by the Food and Drug Administration?

"Our team at Power rated DuraPrep's safety a 3 on the scale, signifying that this intervention has been officially approved by regulatory authorities."

Answered by AI

What other research initiatives have been launched to analyze the efficacy of DuraPrep?

"Currently, 47 trials are underway regarding DuraPrep. Of those clinical investigations, 18 have entered Phase 3. Although the main research is conducted in Bialystok, Podlaskie, a total of 2768 sites worldwide offer this particular treatment trial."

Answered by AI
Recent research and studies
~1200 spots leftby Apr 2025